Skip to main content
Top
Published in: Abdominal Radiology 5/2015

01-06-2015

Multireader evaluation of lesion conspicuity in small pancreatic adenocarcinomas: complimentary value of iodine material density and low keV simulated monoenergetic images using multiphasic rapid kVp-switching dual energy CT

Authors: Michelle M. McNamara, Mark D. Little, Lauren F. Alexander, L. Van Carroll, T. Mark Beasley, Desiree E. Morgan

Published in: Abdominal Radiology | Issue 5/2015

Login to get access

Abstract

Objective

Perform multireader analysis of objective and subjective lesion conspicuity for small pancreatic adenocarcinomas using rapid switching dual energy CT (rsDECT).

Materials and methods

With IRB approval, 51 abdominal multiphasic rsDECT scans in 46 subjects with small (<3 cm) pancreatic adenocarcinomas were retrospectively reviewed by three independent readers for objective and subjective lesion conspicuity. Measured variables during individual, blinded interpretive sessions of separate low (52) keV, PACS-equivalent (70) keV, and iodine material density (MD) image sets included Hounsfield units (HU) and mg/cc iodine for tumor, nontumoral pancreas, and subcutaneous fat. Objective measures included absolute lesion contrast (LC) and contrast to noise ratios (CNR). Subjective measures included image quality, lesion conspicuity, and reader confidence. Reader agreement was measured with kappa statistic; correlation with truth by Pearson coefficient, CNR with repeated mANOVA; subjective quality measures utilized Tukey–Cramer corrections for multiple testing, p < 0.05 considered significant.

Results

Demographics: 26 F, 20 M, mean age 68 years, weight 75 kg, tumor size of 2.3 cm. LC was highest on 52 keV images for all three readers (mean 90.1 HU). Mean CNR for iodine MD images (4.87) was significantly higher than 52 keV (4.13) or 70 keV (3.9). Very high to near-perfect kappa values were observed for all individual measured objective variables but were best for 52 keV images (52 keV 0.89–0.95, 70 keV 0.76–0.83, iodine 0.87–0.92). 70 keV images scored best for subjective image quality; iodine MD images scored best for lesion conspicuity and reader confidence.

Conclusion

We observed very high reader agreement for independent objective rsDECT image variables and subjective rsDECT image scores in patients with small pancreatic adenocarcinomas. Maximal objective tumor to nontumoral LC was depicted on 52 keV and highest CNR on iodine MD images; readers scored the iodine MD images best for lesion conspicuity and confidence.
Literature
1.
go back to reference American Cancer Society (2013) Cancer facts and figures 2013. Atlanta: American Cancer Society American Cancer Society (2013) Cancer facts and figures 2013. Atlanta: American Cancer Society
2.
go back to reference Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER cancer statistics review, 1975–2010, National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Surveillance, Epidemiology, and End Results Program. Accessed 9 June 2013 Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER cancer statistics review, 1975–2010, National Cancer Institute. Bethesda, MD. http://​seer.​cancer.​gov/​csr/​1975_​2010/​, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Surveillance, Epidemiology, and End Results Program. Accessed 9 June 2013
3.
go back to reference Callery MP, Chang KJ, Fishman EK, et al. (2009) Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16:1727–1733CrossRefPubMed Callery MP, Chang KJ, Fishman EK, et al. (2009) Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16:1727–1733CrossRefPubMed
4.
go back to reference Tamm EP, Silverman PM, Charnsangavej C, et al. (2003) Diagnosis, staging, and surveillance of pancreatic cancer. AJR 180(5):1311–1323CrossRefPubMed Tamm EP, Silverman PM, Charnsangavej C, et al. (2003) Diagnosis, staging, and surveillance of pancreatic cancer. AJR 180(5):1311–1323CrossRefPubMed
5.
go back to reference Rahib L, Smith BD, Aizenberg R, et al. (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913–2921CrossRefPubMed Rahib L, Smith BD, Aizenberg R, et al. (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913–2921CrossRefPubMed
6.
go back to reference Marin D, Boll DT, Mileto A, Nelson RC (2014) State of the art: dual-energy CT of the abdomen. Radiology 271(2):327–342CrossRefPubMed Marin D, Boll DT, Mileto A, Nelson RC (2014) State of the art: dual-energy CT of the abdomen. Radiology 271(2):327–342CrossRefPubMed
7.
go back to reference Lu DS, Vedantham S, Krasny RM, et al. (1996) Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures. Radiology 199:697–701CrossRefPubMed Lu DS, Vedantham S, Krasny RM, et al. (1996) Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures. Radiology 199:697–701CrossRefPubMed
8.
go back to reference Fletcher JG, Wiersema MJ, Farrell MA, et al. (2003) Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 229(1):81–90CrossRefPubMed Fletcher JG, Wiersema MJ, Farrell MA, et al. (2003) Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 229(1):81–90CrossRefPubMed
9.
go back to reference Bronstein YL, Loyer EM, Kaur H, et al. (2004) Detection of small pancreatic tumors with multiphasic helical CT. AJR 182(3):619–623CrossRefPubMed Bronstein YL, Loyer EM, Kaur H, et al. (2004) Detection of small pancreatic tumors with multiphasic helical CT. AJR 182(3):619–623CrossRefPubMed
10.
go back to reference Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB Jr (2002) Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 224:764–768CrossRefPubMed Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB Jr (2002) Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 224:764–768CrossRefPubMed
12.
go back to reference Kim JH, Park SH, Yu ES, et al. (2010) Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology 257:87–96CrossRefPubMed Kim JH, Park SH, Yu ES, et al. (2010) Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology 257:87–96CrossRefPubMed
13.
go back to reference Yoon SH, Lee JM, Cho JY, et al. (2011) Small (20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology 259:442–452CrossRefPubMed Yoon SH, Lee JM, Cho JY, et al. (2011) Small (20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology 259:442–452CrossRefPubMed
14.
go back to reference Gangi S, Fletcher JG, Nathan MA, et al. (2004) Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol 182:897–903CrossRefPubMed Gangi S, Fletcher JG, Nathan MA, et al. (2004) Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol 182:897–903CrossRefPubMed
15.
go back to reference Patel BN, Thomas JV, Lockhart ME, Berland LL, Morgan DE (2013) Single-source dual-energy spectral multidetector CT of pancreatic adenocarcinoma: optimization of energy level viewing significantly increases lesion contrast. Clin Radiol 68(2):148–154CrossRefPubMed Patel BN, Thomas JV, Lockhart ME, Berland LL, Morgan DE (2013) Single-source dual-energy spectral multidetector CT of pancreatic adenocarcinoma: optimization of energy level viewing significantly increases lesion contrast. Clin Radiol 68(2):148–154CrossRefPubMed
16.
go back to reference Macari M, Spieler B, Kim D, et al. (2010) Dual-source dual-energy MDCT of pancreatic adenocarcinoma: initial observations with data generated at 80 kVp and simulated weighted-average 120 kVp. AJR 194:W27–W32CrossRefPubMed Macari M, Spieler B, Kim D, et al. (2010) Dual-source dual-energy MDCT of pancreatic adenocarcinoma: initial observations with data generated at 80 kVp and simulated weighted-average 120 kVp. AJR 194:W27–W32CrossRefPubMed
17.
go back to reference Marin D, Nelson RC, Barnhart H, et al. (2010) Detection of pancreatic tumors, image quality, and radiation dose during the pancreatic parenchymal phase: effect of low-tube-voltage, high-tube-currect CT technique—preliminary results. Radiology 256:450–459CrossRefPubMed Marin D, Nelson RC, Barnhart H, et al. (2010) Detection of pancreatic tumors, image quality, and radiation dose during the pancreatic parenchymal phase: effect of low-tube-voltage, high-tube-currect CT technique—preliminary results. Radiology 256:450–459CrossRefPubMed
18.
go back to reference Holm J, Louizou L, Albiin N, et al. (2012) Low tube voltage CT for improved detection of pancreatic cancer: detection threshold for small, simulated lesions. BMC Med Imaging 12:20CrossRefPubMedCentralPubMed Holm J, Louizou L, Albiin N, et al. (2012) Low tube voltage CT for improved detection of pancreatic cancer: detection threshold for small, simulated lesions. BMC Med Imaging 12:20CrossRefPubMedCentralPubMed
19.
go back to reference Lin XZ, Wu ZY, Tao R, et al. (2012) Dual energy spectral CT imaging of insulinoma-value in preoperative diagnosis compared with conventional multi-detector CT. Eur J Radiol 81:2487–2494CrossRefPubMed Lin XZ, Wu ZY, Tao R, et al. (2012) Dual energy spectral CT imaging of insulinoma-value in preoperative diagnosis compared with conventional multi-detector CT. Eur J Radiol 81:2487–2494CrossRefPubMed
20.
go back to reference Klauss M, Stiller W, Pahn G, et al. (2013) Dual-energy perfusion-CT of pancreatic adenocarcinoma. Eur J Radiol 82:208–214CrossRefPubMed Klauss M, Stiller W, Pahn G, et al. (2013) Dual-energy perfusion-CT of pancreatic adenocarcinoma. Eur J Radiol 82:208–214CrossRefPubMed
21.
go back to reference Zhao L, He W, Li J, et al. (2012) Improving image quality in portal venography with spectral CT imaging. Eur J Radiol 81:1677–1681CrossRefPubMed Zhao L, He W, Li J, et al. (2012) Improving image quality in portal venography with spectral CT imaging. Eur J Radiol 81:1677–1681CrossRefPubMed
22.
go back to reference Brook OR, Gourtsoyianni S, Brook A, et al. (2013) Split-bolus spectral multidetector CT of the pancreas: assessment of radiation dose and tumor conspicuity. Radiology 269:139–148CrossRefPubMed Brook OR, Gourtsoyianni S, Brook A, et al. (2013) Split-bolus spectral multidetector CT of the pancreas: assessment of radiation dose and tumor conspicuity. Radiology 269:139–148CrossRefPubMed
23.
go back to reference Kim H, Arnoletti JP, Christein J, et al. (2014) Pancreatic adenocarcinoma: a pilot study of quantitative perfusion and diffusion weighted breath-hold magnetic resonance imaging. Abdom Imaging 39(4):744–752CrossRefPubMed Kim H, Arnoletti JP, Christein J, et al. (2014) Pancreatic adenocarcinoma: a pilot study of quantitative perfusion and diffusion weighted breath-hold magnetic resonance imaging. Abdom Imaging 39(4):744–752CrossRefPubMed
24.
go back to reference Sarver DB, Yester M, Berland LL, Bolus DM, Fineberg NS, Morgan DE (2012) Radiation exposure during single source dual energy spectral MDCT for multiphasic abdominal exams: it’s not what you think. Abstract presented at the scientific session of the Society of Gastrointestinal Radiology, Scottsdale, AZ, March 25, 2012 Sarver DB, Yester M, Berland LL, Bolus DM, Fineberg NS, Morgan DE (2012) Radiation exposure during single source dual energy spectral MDCT for multiphasic abdominal exams: it’s not what you think. Abstract presented at the scientific session of the Society of Gastrointestinal Radiology, Scottsdale, AZ, March 25, 2012
Metadata
Title
Multireader evaluation of lesion conspicuity in small pancreatic adenocarcinomas: complimentary value of iodine material density and low keV simulated monoenergetic images using multiphasic rapid kVp-switching dual energy CT
Authors
Michelle M. McNamara
Mark D. Little
Lauren F. Alexander
L. Van Carroll
T. Mark Beasley
Desiree E. Morgan
Publication date
01-06-2015
Publisher
Springer US
Published in
Abdominal Radiology / Issue 5/2015
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-014-0274-y

Other articles of this Issue 5/2015

Abdominal Radiology 5/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.